{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T21:57:45Z","timestamp":1648504665911},"reference-count":7,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med","J. Jpn. Soc. Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/naika.103.293","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T17:03:31Z","timestamp":1423501411000},"page":"293-298","source":"Crossref","is-referenced-by-count":0,"title":["1. Cardiac Fabry Disease"],"prefix":"10.2169","volume":"103","author":[{"given":"Toru","family":"Kubo","sequence":"first","affiliation":[{"name":"Department of Cardiology, Neurology and Aging Science, Kochi Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"3) Takenaka T, et al: Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol 51: 50-59, 2008.","DOI":"10.1016\/j.jjcc.2007.12.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"4) Kampmann C, et al: Cardiac manifestations of Anderson-Fabry disease in heterozygous females. J Am Coll Cardiol 40: 1668-1674, 2002.","DOI":"10.1016\/S0735-1097(02)02380-X"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.11281\/shinzo1969.39.8_750"},{"key":"4","doi-asserted-by":"crossref","unstructured":"6) Nakao S, et al: An atypical variant of Fabry's desease in men with left ventricular hypertrophy. N Engl J Med 333: 288-293, 1995.","DOI":"10.1056\/NEJM199508033330504"},{"key":"5","doi-asserted-by":"publisher","unstructured":"7) Sachdev B, et al: Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105: 1407-1411, 2002.","DOI":"10.1161\/01.CIR.0000012626.81324.38"},{"key":"6","doi-asserted-by":"crossref","unstructured":"8) Eng CM, et al: Safety and efficacy of recombinant human \u03b1-galactosidase A replacement therapy in Fabry's disease. N Engl J Med 345: 9-16, 2001.","DOI":"10.1056\/NEJM200107053450102"},{"key":"7","doi-asserted-by":"publisher","unstructured":"9) Weidemann F, et al: Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108: 1299-1301, 2003.","DOI":"10.1161\/01.CIR.0000091253.71282.04"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":["1\uff0e\u5fc3Fabry\u75c5"],"language":"en","deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T16:01:35Z","timestamp":1566316895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/103\/2\/103_293\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.103.293","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}